Nightingale Health Oyj (HEL:HEALTH)
Finland · Delayed Price · Currency is EUR 0.8140
-0.0320 (-3.78%)
At close: Jun 16, 2026
Nightingale Health Oyj Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4.8 | 4.69 | 4.36 | 4.18 | 2.31 | 2.31 | |
Revenue Growth (YoY) | -3.15% | 7.69% | 4.21% | 80.80% | 0.35% | 29.43% |
Cost of Revenue | 1.57 | 1.16 | 1.46 | 0.59 | 1.04 | 0.32 |
Gross Profit | 3.23 | 3.54 | 2.9 | 3.59 | 1.28 | 1.99 |
Selling, General & Admin | 8.71 | 8.6 | 8.78 | 9.38 | 6.5 | 6.37 |
Other Operating Expenses | 6.23 | 6.03 | 4.51 | 6.01 | 4.14 | 3.05 |
Operating Expenses | 22.26 | 22.92 | 21.46 | 22.08 | 14.89 | 11.87 |
Operating Income | -19.03 | -19.38 | -18.56 | -18.49 | -13.61 | -9.88 |
Interest Expense | -1.16 | -0.01 | -0.01 | -0 | -0.77 | -0.37 |
Interest & Investment Income | 0.19 | - | - | - | - | - |
Earnings From Equity Investments | -0.06 | -0.04 | -0.03 | -0.03 | -0.02 | 0.13 |
Currency Exchange Gain (Loss) | -0.15 | -0.15 | -0.27 | -0.37 | 0.3 | -0.06 |
Other Non Operating Income (Expenses) | 1.18 | 1.17 | 1.5 | 0.82 | -0.03 | 0.46 |
EBT Excluding Unusual Items | -19.03 | -18.41 | -17.38 | -18.07 | -14.13 | -9.72 |
Gain (Loss) on Sale of Investments | - | - | - | - | -2.07 | - |
Pretax Income | -19.03 | -18.41 | -17.38 | -18.07 | -16.19 | -9.72 |
Income Tax Expense | 0.05 | 0.05 | 0.09 | 0.01 | -0.1 | 0 |
Net Income | -19.07 | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 |
Net Income to Common | -19.07 | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 | 42 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 | 42 |
Shares Change (YoY) | 0.02% | 0.01% | - | 0.17% | 44.56% | 22.85% |
EPS (Basic) | -0.32 | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 |
EPS (Diluted) | -0.32 | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 |
Free Cash Flow | -13.4 | -12.39 | -10.62 | -8.16 | -8.85 | -2.77 |
Free Cash Flow Per Share | -0.22 | -0.20 | -0.18 | -0.14 | -0.15 | -0.07 |
Gross Margin | 67.36% | 75.39% | 66.45% | 85.89% | 55.17% | 86.16% |
Operating Margin | -396.83% | -412.95% | -425.86% | -442.16% | -588.46% | -428.59% |
Profit Margin | -397.77% | -393.37% | -400.71% | -432.40% | -695.68% | -421.91% |
Free Cash Flow Margin | -279.35% | -263.90% | -243.62% | -195.17% | -382.49% | -120.04% |
EBITDA | -16.34 | -14.5 | -14.06 | -14.96 | -11.53 | -9.3 |
D&A For EBITDA | 2.69 | 4.88 | 4.5 | 3.53 | 2.08 | 0.58 |
EBIT | -19.03 | -19.38 | -18.56 | -18.49 | -13.61 | -9.88 |